NYSE: GSK
Glaxosmithkline Plc Stock Ownership

Insider buying vs selling

Have Glaxosmithkline Plc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

GSK Shareholders

What type of owners hold Glaxosmithkline Plc stock?
Institutional
Insider
Retail
We're currently working to improve the accuracy of the Shareholders dataset. If you spot any inaccuracies, let us know at contact (at) wallstreetzen.com
NameHoldSharesValueType
Dodge Cox0.84%45,000,656$1.67BInstitution
Fmr LLC0.37%19,763,199$732.62MInstitution
Renaissance Technologies LLC0.34%18,329,654$679.48MInstitution
Price T Rowe Associates Inc0.33%17,688,257$655.70MInstitution
Capital International Investors0.31%16,505,150$611.85MInstitution
Fisher Asset Management LLC0.30%16,226,217$601.51MInstitution
Royal Bank Of Canada0.29%15,564,595$576.98MInstitution
State Street Corp0.17%9,390,232$348.10MInstitution
Hotchkis Wiley Capital Management LLC0.14%7,404,500$274.48MInstitution
Black Creek Investment Management Inc0.12%6,485,876$240.43MInstitution

1 of 3

Glaxosmithkline Stock Ownership FAQ

Glaxosmithkline (NYSE: GSK) is owned by 5.52% institutional shareholders, 0.00% Glaxosmithkline insiders, and 94.48% retail investors. Dodge Cox is the largest individual Glaxosmithkline shareholder, owning 45.00M shares representing 0.84% of the company. Dodge Cox's Glaxosmithkline shares are currently valued at $1.67B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics